Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
Current Opinion in Drug Discovery & Development|December 1, 2001
The potential pharmacological and toxicological impact of P450 screeningR J RileyJournal of Pharmacological and Toxicological Methods|May 5, 1998
In vitro analysis of the activity of the major human hepatic CYP enzyme (CYP3A4) using [N-methyl-14C]-erythromycinR J Riley, D HowbrookBiochemical Pharmacology|January 22, 1992
Enzymology of the reduction of the potent benzotriazine-di-N-oxide hypoxic cell cytotoxin SR 4233 (WIN 59075) by NAD(P)H: (quinone acceptor) oxidoreductase (EC 1.6.99.2) purified from Walker 256 rat tumour cellsR J Riley, P WorkmanCurrent Drug Metabolism|April 14, 2006
The impact of in vitro binding on in vitro-in vivo extrapolations, projections of metabolic clearance and clinical drug-drug interactionsK Grime, R J RileyBiochemical Society Transactions|May 18, 2001
Predicting drug pharmacokinetics in humans from in vitro metabolism studiesD F McGinnity, R J RileyClinical Obstetrics and Gynecology|March 1, 1993
Collecting and analyzing cord blood gasesR J Riley, J W JohnsonClinical and Experimental Immunology|January 1, 1995
In vitro analysis of metabolic predisposition to drug hypersensitivity reactionsR J Riley, J S LeederXenobiotica; the Fate of Foreign Compounds in Biological Systems|May 11, 2006
Comparative analysis of substrate and inhibitor interactions with CYP3A4 and CYP3A5M G Soars, K Grime, R J RileyXenobiotica; the Fate of Foreign Compounds in Biological Systems|January 10, 2002
Evaluation of the marmoset as a model species for drug glucuronidationM G Soars, R J Riley, B BurchellThe Journal of Pharmacology and Experimental Therapeutics|March 22, 2002
In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearanceM G Soars, B Burchell, R J RileyPageof 5